Abiopharma

🔍 Greiff Andrew S (Executive)

Company: Ryerson Holding Corp (RYZ)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 11,744 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 11,743.71 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of common stock of the Company.
• F2: On March 31, 2026, the reporting person was granted 11,743.71 restricted stock units, of which 3,914.57 will vest on the first anniversary of the grant date, 3,914.57 will vest on the second anniversary of the grant date and 3,914.57 will vest on the third anniversary of the grant date. Vested shares will be delivered to the reporting person not later than 60 days following such vesting dates.